Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposomes (Q41028464)

25 September 2017

Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposomes (English)

1 reference

25 September 2017

0 references

K Konopka

1

1 reference

25 September 2017

J J Rossi

2

1 reference

25 September 2017

P Swiderski

3

1 reference

25 September 2017

V A Slepushkin

4

1 reference

25 September 2017

N Düzgüneş

5

1 reference

25 September 2017

1 June 1998

1 reference

Biochimica et Biophysica Acta

25 September 2017

1 reference

25 September 2017

1372

1 reference

25 September 2017

1

1 reference

25 September 2017

55-68

1 reference

Ribozymes as potential anti-HIV-1 therapeutic agents.

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Therapeutic applications of ribozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Chemically modified RNA: approaches and applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Ribozymes as human therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Intracellular delivery of nucleic acids and transcription factors by cationic liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Liposomes as agents of DNA transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Cationic liposome-mediated RNA transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Long-term noncytopathic productive infection of the human monocytic leukemia cell line THP-1 by human immunodeficiency virus type 1 (HIV-1IIIB).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

HeLa-LAV, an epithelial cell line stably infected with HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Liposomes modulate human immunodeficiency virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

The potential use of catalytic RNAs in therapy of HIV infection and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Lipofectin-aided cell delivery of ribozyme targeted to human urokinase receptor mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Cellular and molecular barriers to gene transfer by a cationic lipid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Optimization of cationic lipid-mediated gene transfer to airway epithelia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Comparison of cell proliferation and toxicity assays using two cationic liposomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2898%2900046-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-2736(98)00046-7

1 reference

25 September 2017

1 reference